Douglas D. Fraser

6.5k total citations · 1 hit paper
161 papers, 4.3k citations indexed

About

Douglas D. Fraser is a scholar working on Epidemiology, Neurology and Emergency Medicine. According to data from OpenAlex, Douglas D. Fraser has authored 161 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 41 papers in Neurology and 31 papers in Emergency Medicine. Recurrent topics in Douglas D. Fraser's work include Traumatic Brain Injury Research (28 papers), Traumatic Brain Injury and Neurovascular Disturbances (28 papers) and Cardiac Arrest and Resuscitation (25 papers). Douglas D. Fraser is often cited by papers focused on Traumatic Brain Injury Research (28 papers), Traumatic Brain Injury and Neurovascular Disturbances (28 papers) and Cardiac Arrest and Resuscitation (25 papers). Douglas D. Fraser collaborates with scholars based in Canada, United States and Italy. Douglas D. Fraser's co-authors include Gediminas Cepinskas, Brian A. MacVicar, Brent A. Reynolds, Angelo L. Vescovi, Samuel Weiss, Tanya Charyk Stewart, Eric K. Patterson, Claudio M. Martin, Ibrahim M. Alharfi and Mark Daley and has published in prestigious journals such as Neuron, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Douglas D. Fraser

153 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells

1993 553 citations Douglas D. Fraser et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas D. Fraser Canada	36	1.1k	935	906	653	570	161	4.3k
Mark S. Wainwright United States	41	1.2k 1.0×	1.4k 1.5×	1.6k 1.8×	714 1.1×	369 0.6×	157	5.0k
Daniel J. Cole United States	36	444 0.4×	379 0.4×	1.0k 1.1×	518 0.8×	333 0.6×	129	3.9k
Paul J. Feustel United States	46	1.3k 1.1×	587 0.6×	1.2k 1.3×	1.2k 1.8×	1.4k 2.4×	274	6.3k
Sonia Villapol United States	32	1.4k 1.3×	577 0.6×	2.7k 3.0×	375 0.6×	321 0.6×	67	5.4k
Jerome Y. Yager Canada	38	492 0.4×	734 0.8×	1.2k 1.4×	321 0.5×	1.2k 2.1×	125	5.4k
Anish Bhardwaj United States	42	1.6k 1.4×	728 0.8×	2.2k 2.4×	1.2k 1.8×	786 1.4×	108	5.2k
M. Ross Bullock United States	41	1.4k 1.3×	1.3k 1.4×	3.1k 3.4×	822 1.3×	206 0.4×	75	5.2k
Adel Helmy United Kingdom	35	1.2k 1.1×	1.2k 1.2×	2.7k 3.0×	414 0.6×	260 0.5×	119	4.4k
James J. Riviello United States	38	548 0.5×	468 0.5×	843 0.9×	1.5k 2.3×	462 0.8×	148	7.0k
Thomas Kossmann Switzerland	49	2.8k 2.5×	1.7k 1.9×	4.1k 4.5×	875 1.3×	435 0.8×	124	8.9k

Countries citing papers authored by Douglas D. Fraser

Since Specialization

Citations

This map shows the geographic impact of Douglas D. Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas D. Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas D. Fraser more than expected).

Fields of papers citing papers by Douglas D. Fraser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas D. Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas D. Fraser. The network helps show where Douglas D. Fraser may publish in the future.

Co-authorship network of co-authors of Douglas D. Fraser

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas D. Fraser. A scholar is included among the top collaborators of Douglas D. Fraser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas D. Fraser. Douglas D. Fraser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nynatten, Logan R. Van, Douglas D. Fraser, Marat Slessarev, et al.. (2025). Predictive enrichment using biomarkers in studies of critically-ill patients with sepsis: a systematic review. Critical Care. 29(1). 504–504.

Spagnolo, P., Enis Cela, Maitray A. Patel, et al.. (2025). Differential expression of plasma proteins and pathway enrichments in pediatric diabetic ketoacidosis. Molecular Medicine. 31(1). 4–4. 2 indexed citations

Fraser, Douglas D., Devika Singh, Enis Cela, et al.. (2025). Neutralizing antibodies to SARS-CoV-2 variants of concern: a pediatric surveillance study. Scientific Reports. 15(1). 11588–11588.

Leonard, Sean, Michael R. Miller, Maitray A. Patel, et al.. (2024). Pediatric sepsis inflammatory blood biomarkers that correlate with clinical variables and severity of illness scores. Journal of Inflammation. 21(1). 3 indexed citations

Patel, Maitray A., et al.. (2024). The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis. Molecular Medicine. 30(1). 3 indexed citations

Spagnolo, P., Enis Cela, Cheril Clarson, et al.. (2024). Metabolomic signature of pediatric diabetic ketoacidosis: key metabolites, pathways, and panels linked to clinical variables. Molecular Medicine. 30(1). 250–250. 3 indexed citations

Iosef, Cristiana, Michael J. Knauer, Logan R. Van Nynatten, et al.. (2023). Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function. Journal of Translational Medicine. 21(1). 377–377. 37 indexed citations

Patel, Maitray A., Michael J. Knauer, Mark Daley, et al.. (2023). Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning. Molecular Medicine. 29(1). 26–26. 25 indexed citations

Cooper, Jennifer, Jean‐Michel Galarneau, Douglas D. Fraser, et al.. (2023). Characterizing Factors Influencing Baseline Plasma Biomarkers for Sport-Related Concussion in Adolescents. Journal of Neurotrauma. 40(15-16). 1638–1650. 6 indexed citations

10.

Ulndreaj, Antigona, Mingyue Wang, George B. Sigal, et al.. (2022). Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens. Clinical Chemistry and Laboratory Medicine (CCLM). 60(7). 1116–1123. 3 indexed citations

11.

Fraser, Douglas D., Michelle Chen, Michael R. Miller, et al.. (2021). Novel severe traumatic brain injury blood outcome biomarkers identified with proximity extension assay. Clinical Chemistry and Laboratory Medicine (CCLM). 59(10). 1662–1669. 3 indexed citations

12.

Stewart, Tanya Charyk, Jason Gilliland, Andrew Clark, et al.. (2020). Evaluation of a population health strategy to reduce distracted driving: Examining all “Es” of injury prevention. The Journal of Trauma: Injury, Infection, and Critical Care. 90(3). 535–543. 7 indexed citations

13.

Dennis, Maureen, Margot J. Taylor, Anne‐Marie Guerguerian, et al.. (2017). Performance Monitoring in Children Following Traumatic Brain Injury Compared to Typically Developing Children. SHILAP Revista de lepidopterología. 4. 2329048X17732713–2329048X17732713.

14.

Inoue, Ken, Eric K. Patterson, Alfredo Capretta, et al.. (2017). Carbon Monoxide–Releasing Molecule-401 Suppresses Polymorphonuclear Leukocyte Migratory Potential by Modulating F-Actin Dynamics. American Journal Of Pathology. 187(5). 1121–1133. 12 indexed citations

15.

Stewart, Tanya Charyk, Andrew Clark, Jason Gilliland, et al.. (2016). Home safe home. The Journal of Trauma: Injury, Infection, and Critical Care. 81(3). 533–540. 12 indexed citations

16.

Alharfi, Ibrahim M., et al.. (2013). Infection Rates, Fevers, and Associated Factors in Pediatric Severe Traumatic Brain Injury. Journal of Neurotrauma. 31(5). 452–458. 33 indexed citations

17.

Al-Sharif, Abdullah, Varsha Thakur, Ram N. Singh, et al.. (2012). Resuscitation volume in paediatric non-haemorrhagic blunt trauma. Injury. 43(12). 2078–2082. 7 indexed citations

18.

Stewart, Tanya Charyk, Jason Gilliland, David A. Tanner, et al.. (2011). Shaken Baby Syndrome and a Triple-Dose Strategy for Its Prevention. The Journal of Trauma: Injury, Infection, and Critical Care. 71(6). 1801–1807. 32 indexed citations

19.

Fraser, Douglas D., Roxanne Ward, Catherine Farrell, et al.. (2010). Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum*. Pediatric Critical Care Medicine. 12(3). 319–324. 81 indexed citations

20.

Choong, Karen, Desmond Bohn, Douglas D. Fraser, et al.. (2009). Vasopressin in Pediatric Vasodilatory Shock: A Multicenter Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 180(7). 632–639. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact